Aaron Ball ‘20 pitched Livongo Health (LVGO) on Monday, December 2, 2019. Livongo is a provider of an integrated suite of solutions for the healthcare industry sold through the employer and managed care channels. Livongo’s current solutions target the chronic conditions of diabetes, prediabetes and weight management, hypertension and behavioral health. Its platform provides cellular-connected devices, supplies, informed coaching, data science-enabled insights and improved access to medications to its members. Livongo currently boasts 207,815 members from 771 clients, which represent over 20% of Fortune 500 companies. Livongo has experienced rapid growth since its founding in 2014 by Bucknell alumnus Glen Tullman (‘81). It is seeking to continue its strong growth through the sale of additional solutions to existing clients and expansion into new markets, notably the fully-insured employer, government and international markets. The class voted to buy 350 shares of LVGO and fund the purchase with the sale of 32 shares of SPY.